Article Versions Notes

Piloni D, Gabanti E, Morosini M, Cassinelli G, Frangipane V, Zavaglio F, Oggionni T, Saracino L, Lettieri S, Arbustini E, et al. Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD. Microorganisms. 2022; 10(12):2339. https://doi.org/10.3390/microorganisms10122339

Piloni, Davide, Elisa Gabanti, Monica Morosini, Gabriela Cassinelli, Vanessa Frangipane, Federica Zavaglio, Tiberio Oggionni, Laura Saracino, Sara Lettieri, Eloisa Arbustini, and et al. 2022. "Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD" Microorganisms 10, no. 12: 2339. https://doi.org/10.3390/microorganisms10122339

Piloni, D., Gabanti, E., Morosini, M., Cassinelli, G., Frangipane, V., Zavaglio, F., Oggionni, T., Saracino, L., Lettieri, S., Arbustini, E., Meloni, F., & Lilleri, D. (2022). Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD. Microorganisms, 10(12), 2339. https://doi.org/10.3390/microorganisms10122339